Assessment of market access policies and instruments for oncology drugs. KU Leuven
Cancer is a leading cause of death worldwide and the problem is predicted to increase next years. Costs for cancer care currently present a large share of the health care budget. High priced drugs and changing demographics promise to strengthen this fact. Budget constraints limit the market access of new, innovative but expensive oncology drugs in public health systems. This project studies instruments for market access of oncology drugs and ...